ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024 14

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024 14

Maternal obesity linked to childhood cancer

by University of PittsburghCredit: CC0 Public DomainA new study from the University of Pittsburgh Graduate School of Public Health and UPMC Hillman Cancer Center found that children born to obese

Updated on: March 12,2024 19

Maternal obesity linked to childhood cancer

by University of PittsburghCredit: CC0 Public DomainA new study from the University of Pittsburgh Graduate School of Public Health and UPMC Hillman Cancer Center found that children born to obese

Updated on:March 12,2024 19

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved

Updated on: March 30,2024 0

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved

Updated on:March 30,2024 0

Breakthrough in understanding of how cancer spreads could lead to better treatments

by Cancer Research UKNALCN loss-of-function in aggressive cancers.a, Differential gene expression between normal PROM1+gastric cells andP1KP-GAC cells (downregulated ion channels are

Updated on: February 18,2024 13

Breakthrough in understanding of how cancer spreads could lead to better treatments

by Cancer Research UKNALCN loss-of-function in aggressive cancers.a, Differential gene expression between normal PROM1+gastric cells andP1KP-GAC cells (downregulated ion channels are

Updated on:February 18,2024 13

Immunotherapy for blood cancer: Remote destruction of tumor cells demonstrated

byPasteur InstituteGating strategies for flow cytometry identification of pro-B-cell tumors. (a) Gating strategy for identifying pro-B-cell tumors expressing the FRET-based caspase 3 reporter (n

Updated on: January 15,2024 17

Immunotherapy for blood cancer: Remote destruction of tumor cells demonstrated

byPasteur InstituteGating strategies for flow cytometry identification of pro-B-cell tumors. (a) Gating strategy for identifying pro-B-cell tumors expressing the FRET-based caspase 3 reporter (n

Updated on:January 15,2024 17

Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun

Updated on: May 25,2024 7

Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun

Updated on:May 25,2024 7

New mammogram rule gives women more details to guard against breast cancer

by Helena Oliviero, The Atlanta Journal-ConstitutionCredit: Unsplash/CC0 Public DomainA new federal rule takes effect Tuesday that could potentially help more women spot breast cancer earlier. The FDA

Updated on: September 28,2024 0

New mammogram rule gives women more details to guard against breast cancer

by Helena Oliviero, The Atlanta Journal-ConstitutionCredit: Unsplash/CC0 Public DomainA new federal rule takes effect Tuesday that could potentially help more women spot breast cancer earlier. The FDA

Updated on:September 28,2024 0

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on: January 08,2024 10

Team establishes a large collection of cholangiocarcinoma models for preclinical drug evaluation and biomarker discovery

by Vall d'Hebron Institute of OncologyCholangiocarcinomas (CCAs) are a highly aggressive and diverse group of malignancies of the biliary tract that currently account for 15% of all liver cancers

Updated on:January 08,2024 10

Researchers identify drug resistance factors for advanced prostate cancer

by Mayo ClinicThe DNA/RNA processing used both single sample and multi-sample analyses as part of the processing. Credit:Molecular Cancer Research(2022). DOI: 10.1158/1541-7786.MCR-22

Updated on: February 20,2024 16

Researchers identify drug resistance factors for advanced prostate cancer

by Mayo ClinicThe DNA/RNA processing used both single sample and multi-sample analyses as part of the processing. Credit:Molecular Cancer Research(2022). DOI: 10.1158/1541-7786.MCR-22

Updated on:February 20,2024 16

Small molecule inhibitors show early-stage promise against YAP fusion-driven cancers

byCincinnati Children's Hospital Medical CenterIn an early proof-of-concept success, a team led by experts at Cincinnati Children's reports that mice induced to develop brain tumors feat

Updated on: January 11,2024 10

Small molecule inhibitors show early-stage promise against YAP fusion-driven cancers

byCincinnati Children's Hospital Medical CenterIn an early proof-of-concept success, a team led by experts at Cincinnati Children's reports that mice induced to develop brain tumors feat

Updated on:January 11,2024 10

Researchers develop new machete technique to slice into cancer genome and study copy number alterations

by Memorial Sloan Kettering Cancer CenterMACHETE enables efficient engineering of genomic deletions. a, Schematic of the MACHETE approach. WT, wild type; HA, homology arm; Puro, puromycin; pA, po

Updated on: February 18,2024 17

Researchers develop new machete technique to slice into cancer genome and study copy number alterations

by Memorial Sloan Kettering Cancer CenterMACHETE enables efficient engineering of genomic deletions. a, Schematic of the MACHETE approach. WT, wild type; HA, homology arm; Puro, puromycin; pA, po

Updated on:February 18,2024 17

Novel inherited variants may raise risk for Hodgkin lymphoma

Novel coding and noncoding gene variants have been identified that may increase the risk for developing Hodgkin lymphoma (HL), according to a study published online Aug. 20 inBlood.Jamie E. Fler

Updated on: January 13,2024 13

Novel inherited variants may raise risk for Hodgkin lymphoma

Novel coding and noncoding gene variants have been identified that may increase the risk for developing Hodgkin lymphoma (HL), according to a study published online Aug. 20 inBlood.Jamie E. Fler

Updated on:January 13,2024 13